U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT07517250) titled 'A Study on the Use of Canakinumab Among Familial Mediterranean Fever and Still's Disease Patients' on April 01.
Brief Summary: This study aims to assess and characterize the treatment patterns, and long-term clinical outcomes and demographic characteristics of patients diagnosed with Familial Mediterranean fever (FMF) and Still's disease (including systemic juvenile idiopathic arthritis [SJIA] and adult-onset Still's disease [AOSD]) that received canakinumab for at least 6 months.
Study Start Date: April 07
Study Type: OBSERVATIONAL
Condition:
Familial Mediterranean Fever
Still Disease
Systemic Juvenile Idiopathic Arthritis
Adul...